Novel Triple-action Pt(IV) prodrugs with carbocyanine and chalcone in axial position: photoactivation, tumor targeting, fluorescent tumor visualization, and high therapeutic efficacy

Pt(IV) prodrugs are highly promising platform for anticancer agents due to the ability to fine-tune the structure and properties of the prodrug by varying the axial ligand conjugated with the Pt(IV) core. In this study, we have synthesized photoactivated Pt(IV) prodrugs with NIR-absorbing cyanine and chalcone in axial positions, which combine the advantages of dual-target chemotherapy, controlled photoactivation, photodynamic therapy, and fluorescent NIR bioimaging. The cyanine-chalcone-based prodrug Pt-4 demonstrated the ability to generate ROS, release carboplatin intracellularly and promote p53 expression under 660 nm light. Pt-4 prodrug demonstrated superior pharmacokinetic properties to carboplatin and excellent fluorescent imaging of CT-26 tumors. In vivo, Pt-4 prodrug + 660 nm light stimulated adaptive immune response in LLC tumors and significantly inhibited tumor growth of homograft CT-26 tumor. Our findings demonstrate excellent potential of Pt(IV)-carbocyanine light-activatable platform for tumor imaging, drug delivery and tumor eradication.

Authors

Institutions

Publication Details

Journal
ChemRxiv
Published
2026-11-16
DOI
https://doi.org/10.26434/chemrxiv.15012242/v1
Primary Topic
Metal complexes synthesis and properties
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Novel Triple-action Pt(IV) prodrugs with carbocyanine and chalcone in axial position: photoactivation, tumor targeting, fluorescent tumor visualization, and high therapeutic efficacy

Sergey Brezgin, Yu. A. Maksimova, Dmitry A. Bunin, Elena Kimovna Beloglazkina et al.
3 links
ChemRxiv
Metal complexes synthesis and properties
preprint

Novel Triple-action Pt(IV) prodrugs with carbocyanine and chalcone in axial position: photoactivation, tumor targeting, fluorescent tumor visualization, and high therapeutic efficacy

Sergey Brezgin, Yu. A. Maksimova, Dmitry A. Bunin, Elena Kimovna Beloglazkina, Alexander G. Martynov, Irina I. Khan, Игорь Александрович Родин, Anastasiya Kostyusheva, Ilya V. Gordeychuk, Ivan Karandashov, Nikolay V. Ul’yanovskiy, Vsevolod V. Volodin, Mikhail F. Vokuev, Olga Olegovna Krasnovskaya, Y.K. Grishin, Irina A. Goptar, Irina V. Arutyunyan, Georgy L. Karetnikov, Daniil V. Spector, Yulia A. Isaeva, Ilia Kuzmichev, A. S. Dubensky, Anastasia Zharova, Maxim E. Stepanov, Roman A. Akasov, Polina S. Nezvanova, Vadim S. Pokrovsky, Yulia A. Duvanova, Anastasia S. Frolova, Gulalek Babayeva, Tatiana V. Egorova, Anna N. Zyrina, Tatiana B. Kazora, Dmitry S. Kostushev
preprint en

Abstract

Pt(IV) prodrugs are highly promising platform for anticancer agents due to the ability to fine-tune the structure and properties of the prodrug by varying the axial ligand conjugated with the Pt(IV) core. In this study, we have synthesized photoactivated Pt(IV) prodrugs with NIR-absorbing cyanine and chalcone in axial positions, which combine the advantages of dual-target chemotherapy, controlled photoactivation, photodynamic therapy, and fluorescent NIR bioimaging. The cyanine-chalcone-based prodrug Pt-4 demonstrated the ability to generate ROS, release carboplatin intracellularly and promote p53 expression under 660 nm light. Pt-4 prodrug demonstrated superior pharmacokinetic properties to carboplatin and excellent fluorescent imaging of CT-26 tumors. In vivo, Pt-4 prodrug + 660 nm light stimulated adaptive immune response in LLC tumors and significantly inhibited tumor growth of homograft CT-26 tumor. Our findings demonstrate excellent potential of Pt(IV)-carbocyanine light-activatable platform for tumor imaging, drug delivery and tumor eradication.

ChemRxiv
Engelhardt Institute of Molecular Biology (RU), Peoples' Friendship University of Russia (RU), Russian Academy of Sciences (RU), Moscow State Pedagogical University (RU), Sechenov University (RU), Lomonosov Moscow State University (RU), Frumkin Institute of Physical Chemistry and Electrochemistry Russian Academy of Sciences (RU), Russian Cancer Research Center NN Blokhin (RU), Institute of Synthetic Polymeric Materials (RU), Geological Institute (RU), Chumakov Institute of Poliomyelitis and Viral Encephalitides (RU), Genetic Technologies (Australia) (AU)
Good health and well-being
Metal complexes synthesis and properties
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon